US surge boosts Dechra
Date added:
08/07/2015
PET pharmaceuticals group Dechra has revealed that its revenue for the year is up by around 10% with the US being its star performer. In a pre-close trading update for its financial year ended 30 June 2015, the group - which is headquartered in Northwich - revealed that revenue from its North American operation had increased by 60% at constant exchange rates. Dechra said it had also seen positive momentum in Europe with revenue growth of 4%. It said this has been driven by the solid performance of its Companion Animal Products ....
Back to all news